164 related articles for article (PubMed ID: 32707527)
1. Discovery of novel small molecule inhibitors of S100P with in vitro anti-metastatic effects on pancreatic cancer cells.
Camara R; Ogbeni D; Gerstmann L; Ostovar M; Hurer E; Scott M; Mahmoud NG; Radon T; Crnogorac-Jurcevic T; Patel P; Mackenzie LS; Chau DYS; Kirton SB; Rossiter S
Eur J Med Chem; 2020 Oct; 203():112621. PubMed ID: 32707527
[TBL] [Abstract][Full Text] [Related]
2. S100P-derived RAGE antagonistic peptide reduces tumor growth and metastasis.
Arumugam T; Ramachandran V; Gomez SB; Schmidt AM; Logsdon CD
Clin Cancer Res; 2012 Aug; 18(16):4356-64. PubMed ID: 22718861
[TBL] [Abstract][Full Text] [Related]
3. S100P promotes pancreatic cancer growth, survival, and invasion.
Arumugam T; Simeone DM; Van Golen K; Logsdon CD
Clin Cancer Res; 2005 Aug; 11(15):5356-64. PubMed ID: 16061848
[TBL] [Abstract][Full Text] [Related]
4. Designing and developing S100P inhibitor 5-methyl cromolyn for pancreatic cancer therapy.
Arumugam T; Ramachandran V; Sun D; Peng Z; Pal A; Maxwell DS; Bornmann WG; Logsdon CD
Mol Cancer Ther; 2013 May; 12(5):654-62. PubMed ID: 23303403
[TBL] [Abstract][Full Text] [Related]
5. The role of S100P in the invasion of pancreatic cancer cells is mediated through cytoskeletal changes and regulation of cathepsin D.
Whiteman HJ; Weeks ME; Dowen SE; Barry S; Timms JF; Lemoine NR; Crnogorac-Jurcevic T
Cancer Res; 2007 Sep; 67(18):8633-42. PubMed ID: 17875703
[TBL] [Abstract][Full Text] [Related]
6. Structural insights into calcium-bound S100P and the V domain of the RAGE complex.
Penumutchu SR; Chou RH; Yu C
PLoS One; 2014; 9(8):e103947. PubMed ID: 25084534
[TBL] [Abstract][Full Text] [Related]
7. S100P: a novel therapeutic target for cancer.
Arumugam T; Logsdon CD
Amino Acids; 2011 Oct; 41(4):893-9. PubMed ID: 20509035
[TBL] [Abstract][Full Text] [Related]
8. S100P acts as a target of miR-495 in pancreatic cancer through bioinformatics analysis and experimental verification.
Jiang PF; Zhang XJ; Song CY; Zhang YX; Wu Y
Kaohsiung J Med Sci; 2021 Jul; 37(7):562-571. PubMed ID: 33949774
[TBL] [Abstract][Full Text] [Related]
9. S100P regulates the collective invasion of pancreatic cancer cells into the lymphatic endothelial monolayer.
Nakayama H; Ohuchida K; Yonenaga A; Sagara A; Ando Y; Kibe S; Takesue S; Abe T; Endo S; Koikawa K; Okumura T; Shido K; Miyoshi K; Nakata K; Moriyama T; Miyasaka Y; Inoue S; Ohtsuka T; Mizumoto K; Nakamura M
Int J Oncol; 2019 Jul; 55(1):211-222. PubMed ID: 31180531
[TBL] [Abstract][Full Text] [Related]
10. A Novel DNA Aptamer Targeting S100P Induces Antitumor Effects in Colorectal Cancer Cells.
Sun W; Luo L; Fang D; Tang T; Ni W; Dai B; Sun H; Jiang L
Nucleic Acid Ther; 2020 Dec; 30(6):402-413. PubMed ID: 32991252
[TBL] [Abstract][Full Text] [Related]
11. Discovery of specific HDAC6 inhibitor with anti-metastatic effects in pancreatic cancer cells through virtual screening and biological evaluation.
Song H; Niu X; Quan J; Li Y; Yuan L; Wang J; Ma C; Ma E
Bioorg Chem; 2020 Apr; 97():103679. PubMed ID: 32120077
[TBL] [Abstract][Full Text] [Related]
12. Expression of S100P and its novel binding partner S100PBPR in early pancreatic cancer.
Dowen SE; Crnogorac-Jurcevic T; Gangeswaran R; Hansen M; Eloranta JJ; Bhakta V; Brentnall TA; Lüttges J; Klöppel G; Lemoine NR
Am J Pathol; 2005 Jan; 166(1):81-92. PubMed ID: 15632002
[TBL] [Abstract][Full Text] [Related]
13. Anti-Cancer Effect of α-Solanine by Down-Regulating S100P Expression in Colorectal Cancer Cells.
Ni X; Chen J; Lu F; Yuan Z; Xu X; Hu Z; Jiang L
Recent Pat Anticancer Drug Discov; 2018; 13(2):240-247. PubMed ID: 29600769
[TBL] [Abstract][Full Text] [Related]
14. The Potent G-Quadruplex-Binding Compound QN-302 Downregulates S100P Gene Expression in Cells and in an In Vivo Model of Pancreatic Cancer.
Ahmed AA; Greenhalf W; Palmer DH; Williams N; Worthington J; Arshad T; Haider S; Alexandrou E; Guneri D; Waller ZAE; Neidle S
Molecules; 2023 Mar; 28(6):. PubMed ID: 36985425
[TBL] [Abstract][Full Text] [Related]
15. Triptonide potently suppresses pancreatic cancer cell-mediated vasculogenic mimicry by inhibiting expression of VE-cadherin and chemokine ligand 2 genes.
Han H; Du L; Cao Z; Zhang B; Zhou Q
Eur J Pharmacol; 2018 Jan; 818():593-603. PubMed ID: 29162433
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the predictive efficiency of S100P on adverse prognosis and the pathogenesis of S100P-mediated invasion and metastasis of colon adenocarcinoma.
Shen ZY; Fang Y; Zhen L; Zhu XJ; Chen H; Liu H; Jiang B; Li GX; Deng HJ
Cancer Genet; 2016 Apr; 209(4):143-53. PubMed ID: 26975699
[TBL] [Abstract][Full Text] [Related]
17. The Role of the C-Terminal Lysine of S100P in S100P-Induced Cell Migration and Metastasis.
Ismail TM; Gross SR; Lancaster T; Rudland PS; Barraclough R
Biomolecules; 2021 Oct; 11(10):. PubMed ID: 34680103
[TBL] [Abstract][Full Text] [Related]
18. Activation of tissue plasminogen activator by metastasis-inducing S100P protein.
Clarke CJ; Gross SR; Ismail TM; Rudland PS; Al-Medhtiy M; Santangeli M; Barraclough R
Biochem J; 2017 Sep; 474(19):3227-3240. PubMed ID: 28798096
[TBL] [Abstract][Full Text] [Related]
19. Screening of Focused Compound Library Targeting Liver X Receptors in Pancreatic Cancer Identified Ligands with Inverse Agonist and Degrader Activity.
Karaboga H; Huang W; Srivastava S; Widmann S; Addanki S; Gamage KT; Mazhar Z; Ebalunode JO; Briggs JM; Gustafsson JÅ; Filgueira CS; Gilbertson SR; Lin CY
ACS Chem Biol; 2020 Nov; 15(11):2916-2928. PubMed ID: 33074669
[TBL] [Abstract][Full Text] [Related]
20. S100P interacts with integrin α7 and increases cancer cell migration and invasion in lung cancer.
Hsu YL; Hung JY; Liang YY; Lin YS; Tsai MJ; Chou SH; Lu CY; Kuo PL
Oncotarget; 2015 Oct; 6(30):29585-98. PubMed ID: 26320193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
